Hantech Bio-Technology Cash Flow Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Net Income	132.42	155.67	148.12	47.47	32.56	55.77
Depreciation & Amortization	33.7	30.35	19.44	18.86	18.24	14.44
Other Amortization	2.86	1.72	1.5	0.47	0.46	0.25
Loss (Gain) From Sale of Assets	-	0.35	0.11	0.55	0	1.1
Stock-Based Compensation	0.1	1.03	0.05	0.17	4.22	7.57
Provision & Write-off of Bad Debts	-0	-0.03	-0.56	0.61	-1.05	0.33
Other Operating Activities	-4.5	-7.07	20.99	7.75	-14.59	12.64
Change in Accounts Receivable	-9.35	7.94	-37.82	-25.73	6.81	-7.53
Change in Inventory	-14.34	13.76	-50.08	-9.72	1.46	-6.37
Change in Accounts Payable	33.76	-52.85	65.47	20.05	-2.73	5.33
Change in Other Net Operating Assets	10.04	-0.13	24.68	2.69	-0.98	27.3
Operating Cash Flow	184.68	150.75	191.91	63.18	44.39	110.84
Operating Cash Flow Growth	31.54%	-21.44%	203.76%	42.33%	-59.95%	270.10%
Capital Expenditures	-22.24	-24.63	-293.94	-82.88	-79.26	-103.6
Sale of Property, Plant & Equipment	-	-	1.83	0.11	-	-
Sale (Purchase) of Intangibles	-1.7	-0.76	-3.28	-0.74	-1.06	-0.32
Investment in Securities	-81.89	-	-1.2	-	-	-
Other Investing Activities	0.01	0.01	0.96	-0.57	0.56	0.7
Investing Cash Flow	-105.82	-25.38	-295.63	-84.07	-79.76	-103.23
Short-Term Debt Issued	-	5	9	10	4	20
Long-Term Debt Issued	-	42.21	269.32	26.34	55.53	63
Total Debt Issued	47.21	47.21	278.32	36.34	59.53	83
Short-Term Debt Repaid	-	-5	-10	-13	-	-20
Long-Term Debt Repaid	-	-215.44	-57.72	-58.45	-14.24	-9.95
Total Debt Repaid	-185.84	-220.44	-67.72	-71.45	-14.24	-29.95
Net Debt Issued (Repaid)	-138.63	-173.23	210.6	-35.11	45.29	53.05
Issuance of Common Stock	29.08	282.4	2.07	44.63	3.17	-
Common Dividends Paid	-87.43	-19.42	-16.84	-	-8.06	-3.72
Other Financing Activities	-	-	-	-	-	4.9
Financing Cash Flow	-266.35	89.75	195.83	9.52	40.4	54.23
Foreign Exchange Rate Adjustments	0.01	0.21	-0.05	0	-0.4	-0.23
Net Cash Flow	-187.5	215.33	92.05	-11.37	4.63	61.61
Free Cash Flow	162.43	126.13	-102.03	-19.7	-34.87	7.23
Free Cash Flow Growth	-	-	-	-	-	-73.56%
Free Cash Flow Margin	22.63%	16.85%	-16.32%	-6.51%	-14.51%	2.71%
Free Cash Flow Per Share	5.29	4.31	-3.60	-0.76	-1.44	0.31
Cash Interest Paid	1.44	3.44	1.42	0.31	0.83	0.71
Cash Income Tax Paid	40.04	47.43	15.49	5.13	21.14	1.78
Levered Free Cash Flow	127.92	88.6	-139.37	-32.65	-42.65	-10.08
Unlevered Free Cash Flow	129.81	91.96	-138.05	-31.74	-41.68	-9.44
Change in Working Capital	20.11	-31.28	2.25	-12.7	4.55	18.74

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.